Impact Capital Partners’s CME Group CME Stock Holding History

Impact Capital Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-927	Closed	-$246K	–	265
2025 Q1	$246K	Sell	927 -18	-2%	-$4.44K	0.09%	226
2024 Q4	$219K	Buy	+945	New	+$217K	0.08%	240

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Impact Capital Partners's CME Position: Q2 2025 in Review

Impact Capital Partners sold out of CME Group (CME) in Q2 2025, closing a stake of 927 shares — an estimated $246K sold.

Impact Capital Partners first reported a position in CME in Q4 2024 and held it in 2 quarters. The position peaked at $246K in Q1 2025. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

Impact Capital Partners reported no remaining CME Group position as of Q2 2025 after selling out during the quarter.
Impact Capital Partners sold 927 CME Group shares in Q2 2025, an estimated $246K.
Impact Capital Partners first reported a position in CME Group in Q4 2024 and held it in 2 quarters.
Impact Capital Partners's CME Group position peaked at $246K in Q1 2025.
1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Impact Capital Partners's 13F filing for Q2 2025, filed 18 Jul 2025.